Your browser doesn't support javascript.
loading
Switching from baricitinib to dupilumab as an advanced-line treatment in pediatric patients with atopic dermatitis: a retrospective cohort study.
Ollech, Ayelet; Cohen-Barak, Eran; Horev, Amir; Bar-Ilan, Efrat; Greenberger, Shoshana.
Afiliação
  • Ollech A; Pediatric Dermatology Service, Shaare Zedek Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.
  • Cohen-Barak E; Department of Dermatology, Emek Medical Center, The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel.
  • Horev A; Pediatric Dermatology Service, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
  • Bar-Ilan E; Pediatric Dermatology Unit, Dermatology Department, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Greenberger S; Pediatric Dermatology Unit, Dermatology Department, Sheba Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Int J Dermatol ; 63(7): e130-e132, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38751334

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Purinas / Pirazóis / Sulfonamidas / Azetidinas / Dermatite Atópica / Anticorpos Monoclonais Humanizados Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Int J Dermatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Purinas / Pirazóis / Sulfonamidas / Azetidinas / Dermatite Atópica / Anticorpos Monoclonais Humanizados Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Int J Dermatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Israel